GlassScriptPhysician profile
Julio Diaz
NPI 1831192129
$2,592.29
in general payments reported to CMS, 2019-2025
19 companies · $456 in 2025
The $456 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $857 · 2020: $57.17 · 2021: $372 · 2022: $289 · 2023: $419 · 2024: $141 · 2025: $456.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,017.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,016.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tosoh Bioscience, INC. | $758.00 | 2019 | |
| Lilly USA, LLC | $351.99 | 2021-2025 | Mounjaro, Jardiance, Trulicity |
| Novo Nordisk INC | $255.32 | 2021-2024 | |
| Glaxosmithkline, LLC. | $250.27 | 2021-2025 | Arexvy, Shingrix |
| Astrazeneca Pharmaceuticals LP | $218.77 | 2023-2025 | Farxiga, Breztri |
| Merck Sharp & Dohme LLC | $161.05 | 2019-2025 | Gardasil 9, Capvaxive, Gardasil |
| Pfizer INC. | $126.19 | 2019-2025 | |
| Genentech USA, INC. | $115.51 | 2019-2022 | |
| Bioventus LLC | $79.84 | 2022-2025 | Gelsyn-3, Durolane |
| Abbott Laboratories | $47.49 | 2025 | Freestyle Libre 3 |
| Daiichi Sankyo INC. | $44.93 | 2021 | |
| Exact Sciences Corporation | $43.58 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Amarin Pharma, INC. | $29.04 | 2020 | |
| Gilead Sciences, INC. | $28.16 | 2019 | |
| Novartis Pharmaceuticals Corporation | $17.62 | 2024 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corcept Therapeutics | $17.11 | 2025 | Korlym |
| Phadia US INC. | $17.04 | 2023 | Immunocap |
| Bayer Healthcare Pharmaceuticals INC. | $15.83 | 2023 | |
| Vbi Vaccine (Delaware) INC. | $14.55 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Julio Diaz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.